AAAAI Podcast: Conversations from the World of Allergy

This episode discusses the allergy practice parameters and how clinicians can utilize these resources. Joint Task Force Co-Chairs David Golden, MD, FAAAAI, and Marcus Shaker, MD, MS, FAAAAI, offer their perspective and insight regarding evidence-based medicine and translation into clinical practice.          

Roxana Siles, MD, FAAAAI, discusses this newly approved biologic that targets thymic stromal lymphopoietin for the treatment of severe asthma. This discussion walks through all the details regarding how best to utilize biologic therapy in asthma management.          

AAAAI Annual Meeting Program Committee Chair, Leonard B. Bacharier, MD, FAAAAI, discusses plans for the upcoming in-person Annual Meeting, February 25-28 in Phoenix, AZ. This update discusses important safety protocols, virtual options for attendees, and insights into all the great programming planned for the meeting. A must listen for all those planning to attend!          

Infectious disease expert Andrew Nowalk, MD, PhD, discusses important information surrounding the new COVID-19 variant, Omicron. Listen now to learn more about COVID-19 mutations, transmission and how this latest variant may or may not impact the pandemic.          

AAAAI President Giselle S. Mosnaim, MD, MS, FAAAAI, discusses her path towards leadership, current presidential initiatives, and an update on the 2022 Annual Meeting.          

John Kelso, MD, FAAAAI, returns to recap all we’ve learned during the past year regarding the safety and efficacy of COVID-19 vaccines, including updates regarding booster doses and recent approval for children 5-11 years of age.          

Nicholas L. Rider, DO, FAAAAI, discusses the new AAAAI course designed to help clinicians better recognize and diagnose primary immunodeficiency. This free online course offers Part IV MOC and continuing education credit.          

Jennifer Namazy, MD, FAAAAI, discusses the accumulating evidence surrounding the safety and efficacy of COVID-19 vaccines during pregnancy. This timely and informative discussion is important for healthcare professionals, patients and the general public.          

David B. Peden, MD, MS, FAAAAI, is the new Editor-in-Chief for The Journal of Allergy and Clinical Immunology: Global (JACI: Global), a new Gold Open Access journal from the AAAAI that is launching in February 2022. Dr. Peden discusses the ins and outs of JACI: Global and how it will impact the specialty of allergy / immunology.          

World-renowned vaccine and infectious disease expert Peter Hotez, MD, PhD, DSc (hon), FASTMH, FAAP, joins us to discuss the latest information surrounding the COVID-19 pandemic. This important update discusses the Delta variant, full FDA approval of the Pfizer vaccine, third vaccine doses, the return to school, and much more.          

Pediatric allergist and food allergy expert Brian Vickery, MD, FAAAAI, joins us to discuss the Delta variant, safety of sending kids back to school and asthma/allergy management in the school setting. This is a timely episode for all parents, school personnel, clinicians and the general public!          

Pamela Guerrerio, MD, PhD, is the principal investigator for a newly launched research study conducted by the National Institutes of Health (NIH). She discusses the research questions being addressed as well as details surrounding inclusion/exclusion criteria and participant involvement.          

Special guest Jen Gunter MD, FRCS(C), FACOG, DABPM, ABPMR, joins the podcast to offer great advice for spotting and avoiding health-related misinformation online. We all need to be savvy with our online searches and use of social media, and healthcare professionals need to learn how and where patients are receiving their information.          

Lead author Mark S. Dykewicz, MD, FAAAAI, walks us through all the details surrounding the recently updated rhinitis parameters. This CME episode is a master class in the diagnosis and treatment of this common condition. Helpful for all medical professionals and patients as well.          

Susan R. Bailey, MD, FAAAAI, the Immediate Past President of the American Medical Association, joins us for our 50th episode to discuss a variety of topics pertinent to healthcare providers, patients and the general public. Dr. Bailey offers valuable perspective and information throughout this timely conversation.          

Rebecca Scherzer, MD, FAAAAI, and Caroline S. Horner, MD, FAAAAI, discuss AAAAI committees and interest sections, as well as ways for members to get more involved. All of us will be inspired to get involved after listening to these two passionate physician educators.          

Sujani Kakumanu, MD, FAAAAI, and Julie Wang, MD, FAAAAI, join us to discuss the AAAAI Leadership Institute. They offer their personal insights surrounding leadership in general, as well as a detailed discussion of the AAAAI’s own cultivated program.          

Lisa Wheatley, MD, MPH, and N. Franklin Adkinson, Jr., MD, FAAAAI, join us to discuss details surrounding a new National Institutes of Health (NIH) study investigating potential causes of rare allergic reactions to COVID-19 vaccines.          

Aleena Banerji, MD, FAAAAI, joins us to discuss the diagnosis and management of drug allergy. Listen to this CME episode to hear one of the world’s leading drug allergy experts offer pearls of wisdom and actionable approaches that anyone can put into place when evaluating suspected drug allergy.          

Media guru, national advocate and community allergist Juanita Mora, MD, discusses the origins of vaccine hesitancy among patients from various backgrounds, and offers practical tips for addressing these complex issues with individual patients and on a broader scale.          

In this engaging conversation, AAAAI President Mary Beth Fasano, MD, MSPH, FAAAAI, offers insight on a variety of topics ranging from the impact of COVID-19 on medicine, the future of medical education, and advice for listeners choosing a career path in allergy/immunology. There is something for everyone in this perfect lead-in to the 2021 AAAAI Virtual Annual Meeting.          

Leonard B. Bacharier, MD, FAAAAI, Chair of the Annual Meeting Program Committee, discusses the exciting sessions and virtual format for this year's meeting, taking place February 26-March 1, 2021. Listen now to help plan your weekend...and beyond!          

John Kelso, MD, FAAAAI, addresses common questions, concerns and misconceptions surrounding the Pfizer-BioNTech and Moderna COVID-19 vaccines. From efficacy to allergy, this broad ranging discussion covers all the important information you need to know.